Yale researchers have made an unexpected discovery—turncoat T cells that help a tumor evade other cancer-fighting immune T ...

Cancer cells impair monocyte-mediated T-cell activation by disrupting inflammatory pathways in the tumor microenvironment.

A research team from the Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences has revealed ...

Tumor-antigen-specific CD8 + T cells are generally thought to help fight against cancer, but here the authors identify a subpopulation of CD8 + T cells that are associated with a poor clinical ...

In a study published in Nature Aging on Nov. 26, a research team from the Shanghai Institute of Nutrition and Health (SINH) ...

The scAtlasVAE model integrates scRNA-seq data to create a CD8+ T cell atlas, enhancing understanding of immune responses in ...

Debilitating chronic fatigue syndrome creates conditions where a kind of immune cell that identifies and kills pathogens, ...

Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver mets, in patients with previously treated microsatellite ...

Tumor-antigen-specific CD8 + T cells are generally thought to help fight against cancer, but here the authors identify a subpopulation of CD8 + T cells that are associated with a poor clinical ...

Cancer immunotherapy has been revolutionized by targeting specific immune subsets within the tumor microenvironment, where T cells play a pivotal role. Gene-engineered T cell strategies and immune ...